Patents by Inventor Lea SCHROEDER

Lea SCHROEDER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10406185
    Abstract: Described is a pharmaceutical composition comprising (a) a parvovirus and (b) an Bcl-2 inhibitor and the use of said composition for treatment of cancer, e.g., a solid tumor. Preferred inhibitors are the BH3 mimetics ABT-737 and ABT-199.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: September 10, 2019
    Assignees: DEUTSCHES KREBSFORSCHUNGSZENTRUM, RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG
    Inventors: Antonio Marchini, Junwei Li, Lea Schroeder, Jean Rommelaere, Karsten Geletneky
  • Publication number: 20180117104
    Abstract: Described is a pharmaceutical composition comprising (a) a parvovirus and (b) an Bcl-2 inhibitor and the use of said composition for treatment of cancer, e.g., a solid tumor. Preferred inhibitors are the BH3 mimetics ABT-737 and ABT-199.
    Type: Application
    Filed: December 28, 2017
    Publication date: May 3, 2018
    Inventors: Antonio MARCHINI, Junwei LI, Lea SCHROEDER, Jean ROMMELAERE, Karsten GELETNEKY
  • Patent number: 9889169
    Abstract: Described is a pharmaceutical composition comprising (a) a parvovirus and (b) an Bcl-2 inhibitor and the use of said composition for treatment of cancer, e.g., a solid tumor. Preferred inhibitors are the BH3 mimetics ABT-737 and ABT-199.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: February 13, 2018
    Assignees: DEUTSCHES KREBSFORSCHUNGSZENTRUM, RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
    Inventors: Antonio Marchini, Junwei Li, Lea Schroeder, Jean Rommelaere, Karsten Geletneky
  • Publication number: 20160082056
    Abstract: Described is a pharmaceutical composition comprising (a) a parvovirus and (b) an Bcl-2 inhibitor and the use of said composition for treatment of cancer, e.g., a solid tumor. Preferred inhibitors are the BH3 mimetics ABT-737 and ABT-199.
    Type: Application
    Filed: December 7, 2015
    Publication date: March 24, 2016
    Inventors: Antonio MARCHINI, Junwei LI, Lea SCHROEDER, Jean ROMMELAERE, Karsten GELETNEKY
  • Patent number: 7920260
    Abstract: A measuring device determines the size, size distribution, and/or concentration of nanoscopic particles or hollow spaces in a measuring sample, the degree of opacity of such measuring samples, or the degree of roughness of surfaces by determining the wavelength and scattering angle dependent intensities of a measuring radiation scattered on a measuring sample. The measuring device comprises a retaining device for a measuring sample to be measured, a detector comprising at least one detector inlet, an evaluation unit, and at least two radiation sources that are respectively at a distance from each other and at a distance from the measuring sample. Via the radiation sources, a ray bundle can in each case be emitted in an essentially parallel beam in the direction of the measuring sample. The ray bundles directed onto the measuring sample are aligned or can be aligned in different angles onto the measuring sample.
    Type: Grant
    Filed: February 2, 2007
    Date of Patent: April 5, 2011
    Assignee: Johann Wolfgang Goethe-Universität
    Inventors: Werner Mäntele, Vitali Vogel, Oliver Klein, Lea Schröder
  • Publication number: 20090185160
    Abstract: The present invention relates to a measuring device to determine the size, size distribution and/or concentration of nanoscopic particles or hollow spaces in a measuring sample, the degree of opacity of such measuring samples, or the degree of roughness of surfaces by determining the wavelength and scattering angle dependent intensities of a measuring radiation scattered on a measuring sample, comprising a retaining device for a measuring sample to be measured, a detector, comprising at least one detector inlet, an evaluation unit and at least two radiation sources, which are respectively at a distance from each other and at a distance from the measuring sample, which comprise a multiple wavelength spectrum or a continuous spectrum, and the radiation intensities of which are adjustable and/or determinable, wherein via the radiation sources one ray bundle can in each case be emitted in an essentially parallel beam in the direction of a measuring sample, and wherein the ray bundles which can be directed onto th
    Type: Application
    Filed: February 2, 2007
    Publication date: July 23, 2009
    Applicant: JOHANN WOLFGANG GOETHE-UNIVERSITAT
    Inventors: Werner Mäntele, Vitali Vogel, Oliver Klein, Lea Schröder